全文获取类型
收费全文 | 2014篇 |
免费 | 127篇 |
国内免费 | 10篇 |
专业分类
耳鼻咽喉 | 11篇 |
儿科学 | 135篇 |
妇产科学 | 54篇 |
基础医学 | 316篇 |
口腔科学 | 35篇 |
临床医学 | 143篇 |
内科学 | 508篇 |
皮肤病学 | 119篇 |
神经病学 | 94篇 |
特种医学 | 27篇 |
外科学 | 186篇 |
综合类 | 21篇 |
预防医学 | 139篇 |
眼科学 | 69篇 |
药学 | 152篇 |
中国医学 | 18篇 |
肿瘤学 | 124篇 |
出版年
2023年 | 18篇 |
2022年 | 12篇 |
2021年 | 63篇 |
2020年 | 50篇 |
2019年 | 72篇 |
2018年 | 87篇 |
2017年 | 67篇 |
2016年 | 70篇 |
2015年 | 72篇 |
2014年 | 114篇 |
2013年 | 123篇 |
2012年 | 187篇 |
2011年 | 184篇 |
2010年 | 93篇 |
2009年 | 73篇 |
2008年 | 111篇 |
2007年 | 68篇 |
2006年 | 103篇 |
2005年 | 89篇 |
2004年 | 83篇 |
2003年 | 66篇 |
2002年 | 51篇 |
2001年 | 24篇 |
2000年 | 15篇 |
1999年 | 17篇 |
1998年 | 13篇 |
1997年 | 13篇 |
1996年 | 12篇 |
1995年 | 8篇 |
1994年 | 8篇 |
1993年 | 11篇 |
1992年 | 15篇 |
1991年 | 14篇 |
1990年 | 13篇 |
1989年 | 12篇 |
1988年 | 9篇 |
1987年 | 11篇 |
1986年 | 10篇 |
1985年 | 12篇 |
1984年 | 6篇 |
1983年 | 8篇 |
1982年 | 10篇 |
1981年 | 5篇 |
1980年 | 8篇 |
1979年 | 9篇 |
1977年 | 7篇 |
1976年 | 4篇 |
1972年 | 3篇 |
1969年 | 3篇 |
1968年 | 3篇 |
排序方式: 共有2151条查询结果,搜索用时 31 毫秒
1.
Samir Gupta MD MSCS Gloria D. Coronado PhD Keith Argenbright MD Alison T. Brenner PhD MPH Sheila F. Castañeda PhD Jason A. Dominitz MD MHS Beverly Green MD MPH Rachel B. Issaka MD MAS Theodore R. Levin MD Daniel S. Reuland MD MPH Lisa C. Richardson MD MPH Douglas J. Robertson MD MPH Amit G. Singal MD MS Michael Pignone MD MPH 《CA: a cancer journal for clinicians》2020,70(4):283-298
Uptake of colorectal cancer screening remains suboptimal. Mailed fecal immunochemical testing (FIT) offers promise for increasing screening rates, but optimal strategies for implementation have not been well synthesized. In June 2019, the Centers for Disease Control and Prevention convened a meeting of subject matter experts and stakeholders to answer key questions regarding mailed FIT implementation in the United States. Points of agreement included: 1) primers, such as texts, telephone calls, and printed mailings before mailed FIT, appear to contribute to effectiveness; 2) invitation letters should be brief and easy to read, and the signatory should be tailored based on setting; 3) instructions for FIT completion should be simple and address challenges that may lead to failed laboratory processing, such as notation of collection date; 4) reminders delivered to initial noncompleters should be used to increase the FIT return rate; 5) data infrastructure should identify eligible patients and track each step in the outreach process, from primer delivery through abnormal FIT follow-up; 6) protocols and procedures such as navigation should be in place to promote colonoscopy after abnormal FIT; 7) a high-quality, 1-sample FIT should be used; 8) sustainability requires a program champion and organizational support for the work, including sufficient funding and external policies (such as quality reporting requirements) to drive commitment to program investment; and 9) the cost effectiveness of mailed FIT has been established. Participants concluded that mailed FIT is an effective and efficient strategy with great potential for increasing colorectal cancer screening in diverse health care settings if more widely implemented. 相似文献
2.
3.
Sami K. Saikaly Jennifer J. Schoch Kiran Motaparthi Archana Shenoy Jacquelyn A. Knapik Nicole R. Bender 《Pediatric dermatology》2021,38(1):249-252
The initial clinical presentation of infantile myofibromatosis can vary from subtle skin changes to large tumors. Here, we describe a case of congenital generalized infantile myofibromatosis which presented with diffuse hypopigmented macules, some with subtle atrophy and telangiectasia. Further workup revealed visceral involvement which led to treatment with systemic chemotherapy. Awareness of this rare clinical presentation is crucial to expedite workup and treatment given the poor prognosis in infants with visceral involvement. 相似文献
4.
5.
6.
7.
8.
9.
Joseph C Ahn Touseef Ahmad Qureshi Amit G Singal Debiao Li Ju-Dong Yang 《World journal of hepatology》2021,13(12):2039-2051
Hepatocellular carcinoma (HCC) is among the leading causes of cancer incidence and death. Despite decades of research and development of new treatment options, the overall outcomes of patients with HCC continue to remain poor. There are areas of unmet need in risk prediction, early diagnosis, accurate pro gnostication, and individualized treatments for patients with HCC. Recent years have seen an explosive growth in the application of artificial intelligence (AI) technology in medical research, with the field of HCC being no exception. Among the various AI-based machine learning algorithms, deep learning algorithms are considered state-of-the-art techniques for handling and processing complex multimodal data ranging from routine clinical variables to high-resolution medical images. This article will provide a comprehensive review of the recently published studies that have applied deep learning for risk prediction, diagnosis, prognostication, and treatment planning for patients with HCC. 相似文献
10.